States Push Back on FDA’s Calls for More Compounding Authority

As the FDA pushes for stronger oversight of pharmacy compounding, state boards of pharmacy argue they are generally capable of overseeing the practice under existing statutory authoritiy.

This article is viewable by subscribers only. To view this article, please select an option below.

Source found here